Bifidobacterium and Bacteroides in the gut microbiome are important to vaccine responsiveness and could be used in vaccine adjuvants in the future, a recent review shows. Gut microbiota in early life can affect the...
Background During the last 30 years, the number of reported TBE cases in Europe has increased by more than 193%, despite two effective TBE vaccines (FSME Immune and Encepur) being available. The raison for this increase...
An interim analysis of data from a phase 3 clinical trial of Russia’s two-dose Gam-COVID-Vac (Sputnik V) coronavirus vaccine involving nearly 20,000 adult volunteers suggests an efficacy of 91.6% against...
Pfizer and BioNTech — the pharmaceutical companies currently leading a phase 3 coronavirus vaccine trial, in which efficacy and safety tests are being conducted — issued a press release explaining how their vaccine...
For a world crippled by the coronavirus, salvation hinges on a vaccine. But in the United States, where at least 4.6 million people have been infected and nearly 155,000 have died, the promise of that vaccine is...